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In situ degradation of metal-alloy implants is unde-
sirable for two reasons: the degradation process may 
decrease the structural integrity of the implant, and the 
release of degradation products may elicit an adverse 
biological reaction in the host. Degradation may result 
from electrochemical dissolution phenomena, wear, or 
a synergistic combination of the two. Electrochemical 
processes may include generalized corrosion, uniformly 
affecting the entire surface of the implant, and local-
ized corrosion, affecting either regions of the device 
that are shielded from the tissue fluids (crevice corro-
sion) or seemingly random sites on the surface (pitting 
corrosion). Electrochemical and mechanical processes 
(for example, stress corrosion cracking, corrosion fa-
tigue, and fretting corrosion) may interact, causing pre-
mature structural failure and accelerated release of 
metal particles and ions. 
The clinical importance of degradation of metal 
implants is evidenced by particulate corrosion and 
wear products in tissue surrounding the implant, which 
may ultimately result in a cascade of events leading 
to periprosthetic bone loss. Furthermore, many au-
thors have reported increased concentrations of local 
and systemic trace metal in association with metal im-
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low but finite prevalence of corrosion-related fracture 
of the implant. 
This review focuses on electrochemical corrosion 
phenomena in alloys used for orthopaedic implants. 
A summary of basic electrochemistry is followed by a 
discussion of retrieval studies of the response of the 
implant to the host environment and the response of 
local tissue to implant corrosion products. The systemic 
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implications of the release of metal particles also are 
presented. Finally, future directions in biomaterials re-
search and development with regard to corrosion pro-
cesses are considered. 
General Concepts Related to Corrosion 
Corrosion of orthopaedic biomaterials is a complex 
multifactorial phenomenon that depends on geometric, 
metallurgical, mechanical, and solution-chemistry pa-
rameters, and a firm understanding of these factors and 
their interactions is required in order to comprehend 
how and why implant materials corrode. In this sec-
tion, the basic electrochemistry of corrosion and the in-
teractions that occur between material, mechanical, and 
solution-chemistry parameters in orthopaedic alloys in 
situ are described. 
Two essential features determine how and why a 
metal corrodes. The first characteristic involves ther-
modynamic driving forces, which cause corrosion (oxida-
tion and reduction) reactions, and the second involves 
kinetic barriers, which limit the rate of these reactions. 
The thermodynamic driving forces that cause corrosion 
correspond to the energy required or released during a 
reaction. The kinetic barriers to corrosion are related to 
factors that impede or prevent corrosion reactions from 
taking place. The basic underlying reaction that occurs 
during corrosion is the increase of the valence state — 
that is, the loss of electrons — of the metal atom to form 
an ion, as expressed by the equation: M <=> Mn* + ne\ 
This oxidation event may result in free ions in solu-
tion, which then can migrate away from the metal surface 
or can lead to the formation of metal oxides, metal 
chlorides, organometallic compounds, or other chemical 
species. These latter forms may be soluble or may precip-
itate out to form solid phases. The solid oxidation prod-
ucts may be subdivided into those that form adherent 
compact oxide films and those that form non-adherent 
oxide, chloride, phosphate, or other particles that can 
migrate away from the metal surface. In all of these 
possible reactions, there is a thermodynamic driving 
force for the oxidation of metal atoms to their ionic form. 
In this case, the driving force is the free energy (AG) 
resulting from these reactions, which can be calculated 
with use of the equation80: 
where AGred is the free energy for the reduction reaction, 
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AG0 is the free energy of the reaction in a defined stan-
dard state, R is the gas constant, T is the temperature, 
and the bracketed values are the activities (or the ap-
proximate concentrations) of the species involved in the 
reaction. If AG is greater than zero, then the reduction 
process requires energy or, alternatively, the oxidation 
process releases energy and will occur spontaneously. 
In general, there are two sources of energy to be 
considered in corrosion processes. The first is a chem-
ical driving force that determines whether corrosion will 
take place under certain conditions. If the free eriergy 
for oxidation is less than zero, then oxidation will occur 
spontaneously, as in the metals in the alloys used for 
orthopaedic implants. The second source of energy oc-
curs when positive and negative charges (metal ions and 
electrons, respectively) are separated from one another 
during corrosion. The ions are released into solution or 
go on to form an oxide or another compound, and the 
electrons are left behind in the metal or undergo other 
electrochemical reactions, such as reduction of oxy-
gen or hydrolysis of water. This separation between the 
charges contributes to what is known as the electrical 
double layer and creates an electrical potential across 
the metal-solution interface (much like a capacitor), as 
expressed by AG = -nFAE, where n is the valence of the 
ion, F is the Faraday constant, and AE is the voltage or 
potential across the interface between the metal and the 
solution. This potential is a measure of the reactivity of 
the metals or the driving force for metal oxidation. The 
more negative the potential of a metal in solution, the 
more reactive it will tend to be. 
At equilibrium, the chemical energy balances with 
the electrical energy, yielding the Nernst equation3": 
[M"+] 
TABLE I 
STANDARD ELECTROCHEMICAL SERIES FOR SELECTED METALS43* 
AE- •- AE° + ^ In 
nt [M] 
which states that there is an electrical potential across 
the interface between the metal and the solution when 
metals are immersed in a solution. 
From this equation, a scale of reactivity of the metal, 
known as the electrochemical series, can be estab-
lished43. This scale ranks the equilibrium potential from 
most positive (least reactive, or most noble) to most 
negative (most reactive, or most base). This ranking is 
based only on thermodynamic considerations — that is, 
if it is assumed that there is no barrier to the oxidation 
of the metal, these are the potentials across the metal-
solution interface. Certain metals owe their resistance 
to corrosion to the fact that their equilibrium potentials 
are very positive, indicating that the chemical driving 
force for oxidation either is very small and negative 
or is positive (Table I). Therefore, there is little or no 
driving force for oxidation unless the potentials of these 
materials are raised well above their equilibrium poten-
tials. Gold and platinum are examples of metals that 
have little or no driving force for oxidation in aqueous 
solutions; hence, they tend to remain in metallic form 
Noble 
Active 
Reaction 
Au3+ + 3e-
Pt2+ + 2e-
Ag+ + e~ 
O2 + 2H20 + 4e" 
Ti(OH)3+ + H+ + e-
H*+e-
Fe3+ + 3e-
Co2+ + 2e~ 
Fe2+ + 2e" 
Cr2+ + 2e-
Cr3+ + 3e" 
2H20 + 2e-
Ti02 + 4H+ + 4e" 
Ti2+ + 2e~ 
Mg+ + er 
Na+ + e -
<=> 
*=> 
<=> 
<=> 
<=> 
0 
<=> 
<=> 
0 
<=> 
<=> 
<=> 
<=> 
0 
0 
<=> 
Au 
Pt 
Ag 
OH-
Ti3+ + H 2 0 
1/2 H 2 
Fe 
Co 
Fe 
Cr 
Cr 
20H-
Ti + 2H20 
Ti 
Mg 
Na 
Potential 
(Volts) 
1.42 
1.20 
0.80 
0.40 
0.06 
0.00 
-0.04 
-0.28 
-0.41 
-0.56 
-0.74 
-0.83 
-0.86 
-1.60 
-2.37 
-2.71 
*These values are based on the standard hydrogen electrode scale. 
The more noble metals (at the top of the list) are less reactive, while 
the more active metals (toward the bottom) are more reactive and have 
a higher driving force for oxidation (corrosion). Note that titanium and 
chromium (particularly the trivalent form) are both very reactive and 
have a high driving force for oxidation. 
indefinitely in the human body. However, metals that 
are commonly used in orthopaedics have more nega-
tive potentials, indicating that, from a chemical driving-
force perspective, they are much more likely to corrode. 
For example, titanium has a very large negative poten-
tial (Table I), indicating a large chemical driving force 
for corrosion (oxidation). If some other process such 
as passivation does not intervene, titanium metal will 
react violently with the surrounding chemical species 
(typically, oxygen, water, or other oxidizing species) and 
will revert to its ionic form. 
The second factor that governs the corrosion pro-
cess of metal biomaterials is kinetic barriers that pre-
vent corrosion not by energetic mechanisms but by 
physical limitation of the rate at which oxidation or 
reduction processes can take place. The well known pro-
cess of passivation, or the formation of a metal-oxide 
passive film on a metal surface, is an example of a ki-
netic limitation to corrosion. In general, kinetic bar-
riers to corrosion prevent the migration of metal ions 
from the metal to the solution, the migration of anions 
from the solution to the metal, and the migration of 
electrons across the metal-solution interface. Passive 
oxide films are the best-known forms of kinetic barriers 
to corrosion, but there are others, including polymeric 
coatings. 
Most alloys used for orthopaedic appliances rely on 
the formation of a passive film to prevent oxidation 
from taking place. These films consist of metal oxides, 
which form spontaneously on the surface of the metal 
in such a way that they prevent transport of metal ions 
and electrons across the film. In order to limit oxidation, 
passive films must have certain characteristics. They 
must be non-porous and must fully cover the metal sur-
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TABLE 
SPECIFICATIONS OF THE AMERICAN SOCIETY FOR TESTING AND MATERIALS 
Alloy System 
Stainless-steel 
316L 
22-13-5 
Cobalt 
Cast 
Forgedt 
Wrought 
Titanium 
Commercially pure 
Extra-low interstitial 
Ti-6A1-4V 
Specification 
F-138 (grade 2) 
F-1314 
F-75 
F-799 
F-90 
F-67 (grade 4) 
F-136 
Fe 
Balance 
Balance 
0.75 max. 
0.75 max. 
3.0 max. 
0.5 max. 
0.25 max. 
C 
0.03 max. 
0.03 max. 
0.35 max. 
0.35 max. 
0.05-0.15 
0.1 max. 
0.08 max. 
Cr 
17-19 
20.5-23.5 
27-30 
26-30 
19-21 
Ni 
13-15.5 
11.5-13.5 
1.0 max. 
1.0 max. 
9-11 
Co 
Balance 
Balance 
Balance 
Ti 
Balance 
Balance 
Al 
5.5-6.5 
V 
0.10-0.30 
3.5-4.5 
*Composition is given as the weight per cent. 
tThe same composition specifications are applicable to the wrought form of this alloy given by specification F-1537. 
face; they must have an atomic structure that limits the 
migration of ions and electrons across the metal oxide-
solution interface; and they must be able to remain on 
the surface of these alloys even with mechanical stress-
ing or abrasion, which can be expected in association 
with orthopaedic devices. In general terms, the more 
atomic defects there are in the oxide, the less able the 
oxide film is to prevent migration of ionic species and 
the lower the kinetic barrier is to corrosion. These 
atomic defects include vacancies, which are missing 
atoms in the oxide crystal, and impurity atoms with 
different valence states within the oxide crystal. Tita-
nium dioxide is very close to being a stoichiometric 
oxide; hence, it does not have many ionic defects. This 
results in an increased resistance to ionic transport. Sev-
eral treatments have been investigated to determine if 
the barrier effect of the oxide film can be improved. 
These treatments include a hot, concentrated nitric-acid 
bath (American Society for Testing and Materials Spec-
ification F86-84), boiling in distilled water107, and anod-
ization. However, detailed investigations with regard to 
changes in the structure of the oxide film that are asso-
ciated with these treatments are incomplete. 
Importantly, mechanical factors, such as fretting, mi-
cromotion, or applied stresses, may cause the oxide film 
to abrade or fracture. When an oxide film is ruptured 
from the metal substrate, unoxidized metal is exposed 
to solution. Such films tend to reform or repassivate, 
and the magnitude of the repassivation current densities 
may be large (for example, as much as one ampere per 
square centimeter35). This is due to the large driving 
forces that are present for the oxidation process; when 
the kinetic barrier is removed, these forces can cause 
oxidation. However, the extent and duration of the ox-
idation currents depend on the repassivation kinetics 
for formation of the oxide film. Hence, the mechanical 
stability of the oxide film as well as the nature of its 
repassivation process is central to its performance in 
orthopaedic applications. 
In order to continue corrosion reactions, the elec-
trons that are left behind in the metal must undergo 
another reaction (a reduction reaction) to be consumed. 
A typical reduction reaction in orthopaedic implants is 
the reduction of oxygen and water to form hydroxide. 
Reduction reactions can take place either very close to 
the corresponding oxidation reaction or far from it. An 
example of the latter is a crevice corrosion reaction, in 
which the crevice solution becomes relatively depleted 
in oxygen; thus, while continued oxidation takes place 
in the crevice, the reduction reaction occurs away from 
it. In any event, in order for corrosion reactions to pro-
gress, there must be a corresponding reduction reaction. 
If the reduction reaction is eliminated, then corrosion 
may be suppressed. 
Virtually all modern metal orthopaedic implants are 
fabricated from one of three alloy systems, the compo-
sition and the mechanical and physical properties of 
which conform to the specifications of the American 
Society for Testing and Materials68 (Table II). There is 
allowable variability in the concentration ranges for the 
elements used in the alloy, which could potentially lead 
to subtle differences in mechanical, physical, or electro-
chemical properties. The potential variability in proper-
ties due to slight differences in composition, however, 
is minor compared with the potential variability intro-
duced by differences in fabrication methodology, heat 
treatment, cold-working, and surface-finishing. Surface 
treatments may be particularly important for corrosion 
and wear properties. Such treatments may involve shot-
peening or nitriding and implantation of ions to harden 
the surface, polishing to remove asperities, and passiv-
ation to thicken the protective oxide. 
When two dissimilar metals are in contact in an 
electrolyte solution, there is an electrical potential dif-
ference between them (Table I), resulting in a flow 
of electrons from the more active to the more noble 
metal. This process is termed galvanic corrosion and 
results in a corrosive attack on the active metal (anode) 
and in relative protection of the more noble metal 
(cathode). Contact between dissimilar metals immersed 
in an electrolyte may occur commonly in orthopaedic 
clinical practice. Examples include a stainless-steel cer-
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FOR THE COMPOSITION OF ALLOYS USED IN ORTHOPAEDIC IMPLANTS68* 
Mo Mn Si Cu Nb W o 
2-3 
2-3 
5-7 
5-7 
2.00 max. 
4.0-6.0 
1.0 max. 
1.0 max. 
1.0-2.0 
0.025 max. 
0.025 max. 
0.04 max. 
0.01 max. 
0.010 max. 
0.03 max. 
0.75 max. 
0.75 max. 
1.0 max. 
1.0 max. 
0.40 max. 
0.10 max. 
0.20-0.40 
0.25 max. 
0.5 max. 
0.05 max. 
0.50 max. 
0.50 max. 0.10-0.30 
14-16 
0.4 max. 
0.13 max. 
0.0125 max. 
0.012 max. 
clage wire in contact with a cobalt or titanium-alloy 
femoral stem, a cobalt-alloy femoral head in contact 
with a titanium-alloy femoral stem, and a titanium-alloy 
screw in contact with a stainless-steel plate. Although 
it is generally good practice to avoid contact between 
dissimilar metals, the presence of a passivating oxide 
film alters the kinetics of the corrosion reaction so that 
certain combinations of dissimilar metals are not ac-
companied by accelerated galvanic corrosive attack. 
Under static conditions in which there is no relative 
motion (fretting) between the metals, a galvanic couple 
consisting of cobalt alloy and titanium alloy is stable — 
that is, there is no accelerated corrosive attack. How-
ever, a combination of stainless steel and cobalt alloy or 
one of stainless steel and titanium alloy is unstable (the 
steel is more susceptible to attack), and use of either 
combination should be avoided42,5963•". 
Galvanic effects also may be created by slight dif-
ferences in composition (as already discussed) or by 
differences in metal processing (for example, the use of 
cast as well as forged cobalt alloy). These more sub-
tle galvanic effects do not seem to result in substantial 
corrosive attack in the spontaneously passivating metal 
systems used in orthopaedic applications. Therefore, 
couples consisting of stainless steel and stainless steel83, 
cobalt alloy and cobalt alloy81, and titanium alloy and 
titanium alloy are considered stable under static condi-
tions. In the presence of fretting, however, the situation 
may change because the passivating oxide layer may be 
abraded away, exposing bare metal to the electrolyte 
solution. In this setting, accelerated corrosion may occur 
with any combination of metals depending on the na-
ture of the fretting motion, the local solution chemistry, 
and the microstructure of the metals. 
A wide variety of methodologies are used to assess 
the corrosion properties of orthopaedic alloys. These 
include immersion-testing, electrochemical tests such 
as anodic polarization and linear polarization, and other 
specialized tests such as impedance spectroscopy and 
stripping analysis. These tests are used to investigate 
the rate of ion release, the electrochemical conditions 
that cause oxidation and reduction processes, and the 
electrical nature of the interface. Other methodologies 
allow imaging of the microscopic electrochemical pro-
cesses occurring at a corroding alloy-solution interface36. 
There also are several testing methods related to com-
bined mechanical-electrochemical processes such as 
fretting corrosion, stress corrosion, and corrosion fa-
tigue. These tests typically evaluate how an alloy resists 
failure in the presence of both processes. A full discus-
sion of these methodologies is beyond the scope of this 
review and is available elsewhere3046. 
Current Corrosion Processes in Orthopaedics 
It is important to understand that the corrosion of 
orthopaedic biomaterials is not just an exercise in phys-
ics and chemistry. There are real problems related to the 
corrosion of implants that are in current clinical use. 
Corrosion at Modular Interfaces 
of Joint-Replacement Components 
A current problem related to orthopaedic alloys is 
corrosion at the taper connections of modular joint-
replacement components. With the large and growing 
number of total joint designs that include metal-on-
metal conical taper connections, the effects of crevices, 
stress, and motion take on increasing importance. Re-
cent retrieval studies have shown that severe corrosive 
attack can occur in the crevices formed by these tapers 
in vivo (Fig. I)2122-3465. Gilbert et al. reported that approx-
imately 16 to 35 per cent of 148 retrieved total hip 
implants showed signs of moderate-to-severe corro-
sive attack in the head-neck taper connection34. This 
attack was observed in components consisting of a Ti-
6Al-4V-alloy femoral stem and a cobalt-alloy femoral 
head as well as in those consisting of a cobalt-alloy stem 
and a cobalt-alloy head. It has been postulated that 
this corrosion process is the result of a combination 
of stress and motion at the taper connection and the 
crevice geometry of the taper33. The stresses resulting 
from use of the prosthesis cause fracture and abrasion 
of the oxide film covering these passive metal surfaces. 
This in turn causes changes in the metal surface poten-
tial, making it more negative, and in the chemistry of 
the crevice solution as the oxides continuously fracture 
and repassivate. Such changes may result in deaeration 
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(loss of oxygen) of the crevice solution and in a decrease 
of the pH in the crevice3234, as is expected in crevice 
corrosive attack. The ultimate result of this process is a 
loss of the oxide film and its kinetic barrier effect and 
an increase in the rate of corrosive attack in the taper 
region. 
Severe and extensive corrosive attack has been seen 
primarily in cobalt-alloy systems with modular taper 
connections. However, corrosive attack in titanium-alloy 
stems also has been reported36. 
The corrosion processes in cobalt alloy have con-
sisted of intergranular corrosion, etching, selective dis-
solution of cobalt, and formation of chromium-rich 
particles including oxides, oxychlorides, and phosphates. 
The corrosion products generated at the taper connec-
tions have migrated into the periprosthetic tissue and 
the bearing surface of the acetabular component94. We 
know of three instances in which a retrieved cobalt-alloy 
stem had such extensive intergranular corrosion that 
fatigue failure had ensued at its neck3754. 
A key factor that may contribute to relative mo-
tion (fretting) at modular connections and ultimately to 
abrasive loss of the passivating oxide layer is angular 
mismatch between the taper on the male aspect of the 
connection and the bore on the female aspect. Such 
a mismatch may result if the tolerances are relatively 
large, leading to poor mechanical stability of the con-
nection. In this situation, the loads produced during the 
normal gait cycle may dislodge the interference fit of the 
modular connection, leading to disruption of the metal 
surfaces and initiation of the cascade just described33. 
These observations point to the effect of combined 
FIG. 1 
Photograph of the neck-taper region of a modular prosthesis in 
which both the head and the stem were made of cobalt alloy. The 
surface of the neck that had been mated with the head was pitted, 
etched, and covered with thin films of black corrosion products. In 
contrast, the area that had been at the opening to the head-neck 
junction (arrows) had thick, glassy, green deposits of a chromium-
phosphate-rich corrosion product (x 5). (Reprinted, with permission, 
from: Urban, R. M ; Jacobs, J. J.; Tomlinson, M. J.; Gavrilovic, X; and 
Andersen, M. E.: Migration of corrosion products from the modular 
head junction to the polyethylene bearing surface and interface 
membranes of hip prostheses. In Total Hip Revision Surgery, p. 63. 
Edited by J. O. Galante, A. G. Rosenberg, and J. J. Callaghan. New 
York, Raven Press, 1995.) 
stresses and motion and to the electrochemical pro-
cesses that occur at metal oxide-solution interfaces. The 
mechanical integrity of the oxide films that form on 
these alloys is essential for the long-term stability and 
survival of the implant. 
Internal Fixation Devices 
The development of corrosion-resistant, biocompat-
ible metal alloys was one of several essential factors 
in the evolution of internal fixation as a treatment for 
closed fractures. The history of this process, until the 
precursors of modern-day alloys were introduced, was 
described in detail by Venable and Stuck97 and, more 
recently, by Peltier78. Two case reports in which Lane 
plates were removed after more than fifty years pro-
vide additional indication of the corrosion of these de-
vices and the deposition of large amounts of corrosion 
products in the surrounding tissue24-93. Hundreds of in-
ternal fixation devices and early joint-replacement pros-
theses were examined in retrieval studies in the 1960s 
and 1970s19'20'82'85'86-101'104-106. Many of the stainless-steel and 
cobalt-chromium-alloy devices that were used during 
this period were prone to accelerated corrosion because 
of improper selection of materials, faulty fabrication 
techniques, and use of mixed metals. These deficien-
cies have largely been eliminated in modern implants 
through sound metallurgical practice and fabrication 
processes. Although modern, single-part devices used 
as permanent implants rarely show visible signs of cor-
rosion68, Cook et al. found some degree of interface 
crevice corrosion in 89 per cent of the plates and 88 
per cent of the screws of 250 multiple-part stainless-
steel internal fixation devices removed between 1977 
and 198523. 
Local Tissue Effects 
The tissue surrounding modern implants may in-
clude areas of osseointegration and fibrous encapsula-
tion, and there may be a variable foreign-body response 
to the polyethylene and bone-cement debris produced 
by joint-replacement devices. Although there is no spe-
cific histological evidence of the slow release of metal 
species that is thought to occur in association with all 
metal implants, accelerated corrosion and a tissue re-
sponse that can be related directly to identifiable cor-
rosion products have been demonstrated in the tissue 
surrounding multiple-part devices92-94-105'106. 
Stainless Steel 
The work of Williams and Meachim104, Winter105106, 
Sevitt82, and French et al.31 provides correlated metal-
lurgical and histopathological observations of the local 
tissue response to the corrosion products of stainless-
steel implants used for fixation of long bones. Winter 
identified these corrosion products with use of electron-
microprobe energy-dispersive x-ray analysis and elec-
tron diffraction106. Histological sections of the tissue 
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FIG. 2 
Histological section, obtained from the cadaver of a patient in whom a fracture of the hip had been treated with internal fixation; the 
duration of implantation was unknown. The section shows microplates (which appear green), high in chromium, from a fibrous membrane 
surrounding the corroded stainless-steel screw-plate junction. The largest individual particles were extracellular and measured as much as 
forty micrometers in their greatest dimension. Smaller particles were contained within macrophages (hematoxylin and eosin, x 500). 
(Reprinted, with permission, from: Jacobs, J. J.; Gilbert J. L.; and Urban, R. M.: Corrosion of metallic implants. In Advances in Operative 
Orthopedics, edited by R. N. Stauffer. Vol. 2, p. 294. St. Louis, C. V. Mosby, 1994.) 
surrounding stainless-steel internal fixation devices gen-
erally show encapsulation by a fibrous membrane with 
little or no inflammation over most of the device85. 
At the screw-plate junctions, however, the membrane 
often contains macrophages, foreign-body giant cells, 
and a variable number of lymphocytes in association 
with two types of corrosion products: iron-containing 
hemosiderin-like granules, and microplates, which con-
sist of relatively larger particles of a chromium com-
pound (Fig. 2). Microplates have variable morphological 
characteristics and appear within the tissue as closely 
packed, plate-like aggregates of particles ranging in 
size from 0.5 to 5.0 millimeters. They often are found 
free within acellular collagen or necrotic tissue. Several 
multinucleated foreign-body giant cells are usually pres-
ent within or bordering collections of these particles. In 
hematoxylin-and-eosin preparations, most microplates 
are yellow or apple-green; however, many stain darkly 
with hematoxylin, and these microplates also react 
strongly to stains for iron. Electron-microprobe energy-
dispersive x-ray analyses have indicated that microplates 
are a chromium compound containing iron and a sub-
stantial amount of phosphorous106. The chromium-to-
iron ratio of microplates is invariably higher than that of 
the stainless-steel alloy. 
Hemosiderin-like granules often surround collec-
tions of microplates, but the granules may be found 
alone as well. The granules are yellow-brown, mainly 
spherical, and 0.1 to three micrometers or more in di-
ameter. They are predominantly intracellular and are 
found most often in macrophages, but they may also 
be found in fibrocytes. They react strongly for trivalent 
iron with use of the Prussian-blue reaction, and they 
closely resemble the hemosiderin pigment from residue 
of blood in the tissue. X-ray diffraction has indicated106 
that the granules consist of a mixture of at least two iron 
oxides, <xFe203 and rjFe203, and the hydrated iron oxides, 
aFe 20 3H 20 and rjFe203H20. 
Solid products of corrosion also have been reported 
in association with accelerated corrosion of stainless-
steel femoral stems used in hip replacement1775 and with 
spinal instrumentation73 made of stainless steel. Al-
though these corrosion products may be expected to 
be similar in composition to those of fracture-fixation 
plates and screws, they have not been subjected to de-
tailed microchemical analysis, to our knowledge. 
Cobalt-Based Alloys 
We analyzed the migration of solid corrosion prod-
ucts to the periprosthetic tissue in a study of twenty-
five modular cobalt-alloy total hip-replacement femoral 
components (made by a number of different manu-
facturers) that had been retrieved at the time of revision 
or autopsy54'94,96. The corrosion products were similar re-
gardless of whether the head-neck couple consisted of 
cobalt alloy and cobalt alloy, cobalt alloy and titanium 
alloy, or cobalt alloy and alumina ceramic. The principal 
corrosion product was identified, with use of electron-
VOL. 80-A, NO. 2, FEBRUARY 1998 
274 J. J. JACOBS, J. L. GILBERT, AND R. M. URBAN 
FIG. 3 
Schematic drawing showing the locations of corrosion products 
from a corroded modular hip prosthesis. A = thin interfacial layer of 
mixed oxides and chlorides within the crevice formed by the junc-
tion of the head and the neck taper, and B = thicker deposits of 
chromium-orthophosphate hydrate-rich corrosion products around 
the opening of the crevice. (Reprinted, with permission, from: Urban, 
R. M.; Jacobs, J. X; Gilbert, J. L.; Rice, S. B.; Jasty, M.; Bragdon, C. R.; 
and Galante, J. O.: Characterization of solid products of corrosion 
generated by modular-head femoral stems of different designs and 
materials. In Modularity of Orthopedic Implants, edited by D. E. 
Marlowe, J. E. Parr, and M. B. Mayor. American Society for Testing 
and Materials Special Technical Publication 1301, p. 36. West Con-
shohocken, Pennsylvania, American Society for Testing and Materi-
als, 1997.) 
microprobe energy-dispersive x-ray analysis as well as 
Fourier-transform infrared microprobe spectroscopy, as 
a chromium-orthophosphate hydrate-rich material. This 
corrosion product was present at the modular head-neck 
junction (Fig. 3) and as particles within the joint pseudo-
capsules, within the bone-implant interface membranes, 
and at sites of femoral osteolytic lesions5494-96. In vitro 
studies of the cellular response to particles fabricated 
from commercial preparations of chromium phosphate 
demonstrated that the material is a potent macrophage-
monocyte activator and has the capacity to stimulate 
bone resorption in organ culture in a dose-dependent 
manner61. 
In several instances, particles of the chromium-
orthophosphate hydrate-rich material were found at the 
bearing surface of the polyethylene acetabular liners, 
suggesting their participation in three-body wear and 
an increased production of polyethylene debris94. Par-
ticles of the corrosion product found in the tissue ranged 
in size from submicrometer to aggregates as large as 500 
micrometers. On visualization with light microscopy, the 
particles were similar in appearance to the chromium-
containing microplates observed in association with cor-
roded stainless-steel implants. They were plate-like, pale 
yellow or green, translucent, and usually unstained in 
hematoxylin-and-eosin preparations (Fig. 4). The larger 
particles were free within areas of marked fibrosis or 
necrosis or were associated with foreign-body giant 
cells. Most particles were less than five micrometers 
in size and were found within macrophages. In stained 
sections, these small particles imparted a granular ap-
pearance to the cells that contained them. The particles 
were not birefringent in polarized light. On scanning-
electron-microscope backscattered-electron images of 
unstained sections, the particles were demonstrated by 
mm?& * % ^S&& t.-f£TC. :«*feSi mCJX3l*£ibateLJ FIG. 4 
Photomicrograph showing foreign-body giant cells surrounding several fifty to seventy-micrometer-thick chromium-orthophosphate 
hydrate-rich particles in an area of marked fibrosis in the joint pseudocapsule adjacent to a corroded modular hip prosthesis (hematoxylin and 
eosin, x 500). 
THE JOURNAL OF BONE AND JOINT SURGERY 
CORROSION OF METAL ORTHOPAEDIC IMPLANTS 275 
their bright appearance because of the relatively high 
atomic number of chromium. 
Mathiesen et al. reported extensive necrosis of peri-
prosthetic tissue due to metal toxicity in association with 
four of nine cobalt-chromium-alloy Lord hip prosthe-
ses that had been inserted without cement and had been 
retrieved at revision65. All four implants had bone and 
soft-tissue discoloration as well as black deposits of cor-
rosion products at the modular head-neck junction. The 
corrosion deposits were visible on radiographs that had 
been made before the revision of one implant; they 
appeared as a radiopaque shadow at the superior angle 
between the head and neck. Histological sections of 
the tissue surrounding the corroded prostheses showed 
extensive necrosis and various degrees of histiocytic and 
foreign-body giant-cell proliferation as well as infil-
tration of lymphocytes and plasmacytes. Vascular in-
flammation was present in association with two of the 
implants65. Svensson et al. reported in detail on one of 
these patients, who had an extensive soft-tissue reaction 
that clinically mimicked a sarcoma92. The patient had a 
history of possible allergic skin reactions and, after the 
revision, had a positive cutaneous reaction to cobalt and 
chromium solutions on dermal tests. No neoplastic cells 
were found in the specimens that had been obtained 
at revision. Histopathologically, there was extensive ne-
crosis, fibrosis, and inflammation. The inflammation was 
dominated by lymphocytes, macrophages, and a substan-
tial number of eosinophils. Several small vessels demon-
strated obliterative, necrotizing arteritis. Epithelioid 
granulomas and giant cells containing metal particles 
also were observed. These findings suggested a hyper-
sensitivity reaction, partly of the cell-mediated type, 
leading to a chronic granulomatous inflammation and 
vasculitis that probably were triggered by local release 
of metal ions from the corroding modular junction92. 
We reported an unusual foreign-body reaction to 
particulate products of corrosion and wear in the tis-
sue around a failed total knee implant that had been 
inserted without cement and that was composed of 
several different cobalt alloys51. The patient had a tu-
morlike mass in the right knee in association with ip-
silateral inguinal adenopathy. Radiographs revealed 
a failed metal-backed patellar component, free metal 
debris, and osteolysis adjacent to fixation screws in 
the proximal aspect of the tibia. The histological ap-
pearance of lymph nodes and the tumor was that of 
sarcoid-like non-caseating granulomas associated with 
extensive cobalt-alloy debris51. 
Titanium-Based Alloys 
The degradation products that have been observed 
in histological sections of tissue adjacent to titanium-
based alloys generally have been of a different nature 
than the precipitates associated with stainless-steel and 
cobalt-based alloys that have undergone accelerated 
corrosion. 
Despite the remarkable resistance of titanium-based 
alloys to corrosion, there have been several reports 
of discoloration due to metal debris in the peripros-
thetic tissue. Agins et al. reported a marked histiocytic, 
lymphoplasmacytic, and foreign-body giant-cell reac-
tion to abundant metal, polyethylene, and bone-cement 
debris in the tissue around nine titanium-alloy stems 
that had been revised because of aseptic loosening or 
infection1. Focal necrosis was seen in all of the hips. 
Atomic absorption spectrophotometry, performed on 
samples of the tissue removed from paraffin-tissue 
blocks, revealed that the ratios of titanium, aluminum, 
and vanadium were similar to those in the alloy, sug-
gesting that the metal debris represented wear particles 
from the head or stem rather than precipitated dissolu-
tion products'. 
Black et al. reported the clinical failure of a total 
hip-replacement prosthesis made of Ti-6A1-4V alloy and 
ultra-high molecular weight polyethylene". Both com-
ponents had been fixed with bone cement. The failure 
was due to excessive wear of the titanium-alloy femoral 
head in the absence of loosening of either component. 
In contrast to the findings of Agins et al.1, the tissue 
response in the joint pseudocapsule of this patient was 
characterized by fine metal debris within histiocytes in 
the absence of lymphoplasmacytic leukocytes, foreign-
body giant cells, or necrosis. Electron-microprobe an-
alysis of the metal particles demonstrated titanium, 
aluminum, and vanadium in proportion to their concen-
trations in Ti-6A1-4V alloy". 
Meachim and Williams studied nineteen commer-
cially pure titanium, non-articulating implants (seven-
teen pin-and-plate devices and two Harrington rods) and 
the surrounding tissue67. The specimens were examined 
with histological and metallurgical techniques, and the 
titanium content of the tissue adjacent to the implant was 
estimated with neutron-activation analysis. Variable 
amounts of titanium particles within macrophages and 
fibrocytes were found within densely collagenous mem-
branes that were adjacent to the implant. Foreign-body 
giant cells were rare. No specimen had metallurgical 
evidence of corrosion other than areas that appeared 
duller than others on gross examination. No obvious 
relationship was found between the titanium content of 
the tissue and the presence of inflammatory cells, the 
presence of granulation tissue, or the amount of necrotic 
debris at the tissue-implant interface67. 
Willert et al. reported the unique observation of 
crevice corrosion in association with twenty-eight Miil-
ler straight-stem femoral components, made of Ti-6A1-
4V or Ti-Al-Nb alloy, that had been implanted with 
bone cement during total hip replacements102. The re-
trieved components had been in situ for a mean of 
twenty-six months. Pain was the primary reason for 
revision. Corrosion products in the form of violet or 
black deposits and white deposits, described as tita-
nium oxides and hydroxides, were found at the interface 
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between the stem and the surrounding bone cement, 
particularly at the distal aspect of the stem. Particles 
of the corrosion products in the periprosthetic tissue 
appeared as highly birefringent, translucent, rounded 
grains and rectangular plaques. The smaller of these 
particles, found within macrophages and giant cells (of-
ten together with contrast-medium material from the 
cement), occasionally formed cellular granulomas102. 
More typically, the particles observed in local tis-
sue surrounding titanium-alloy implants appear to be 
wear products with the same elemental composition as 
the parent alloy1" rather than precipitated corrosion 
products, as has been demonstrated in association with 
stainless-steel and cobalt-alloy components. However, 
this fine wear debris presents an enormous surface area 
for electrochemical dissolution, which, in all likelihood, 
is a major factor contributing to the local cellular re-
sponse as well as the systemic increases in titanium that 
have been measured2649. 
Remote and Systemic Effects 
General Considerations 
There is a long clinical experience with permanent 
and temporary metal implants7897. The biocompatibility 
of such implants with regard to the local tissue reaction 
has always been a concern. The implant, or wear debris 
generated from it, may release chemically active metal 
ions into the tissue. Although these ions may stay bound 
to local tissue, there is an increasing recognition that 
they may also bind to protein moieties that are trans-
ported in the bloodstream and lymphatics and, hence, 
to remote organs"0. There are four basic issues associ-
ated with metal-ion release: the amount of metal re-
leased from the implant, the site to which the metal is 
transported and the quantity that is transported, the 
chemical form of the released metal (for example, in-
organic precipitate or soluble organometallic complex), 
and the pathophysiological consequences of such metal 
release. There is an increasing body of literature ad-
dressing the first two questions as they relate to to-
tal joint replacement; however, little is currently known 
about the latter two areas. 
The concern about the release and distribution of 
metal degradation products is justified by the known 
potential toxicities of titanium, aluminum, vanadium, 
cobalt, chromium, and nickel (the elements used in 
modern orthopaedic alloys)6100. The toxicology of these 
elements has been described in several review arti-
cjes27.4o,56,6o,88,io3 j n g e n e r a i terms, metal toxicity can pre-
sent as metabolic alterations, alterations in host-parasite 
interactions, immunological sensitization by metal 
hapten moieties (specific immunological activation), 
non-specific immunological suppression due to antiche-
motactic properties1370, and chemical carcinogenesis8489. 
However, when the litany of documented toxicities of 
these elements is considered, it should be emphasized 
that they generally apply to soluble forms of the ele-
ments and may not apply to the degradation products 
of prosthetic implants. 
The carcinogenic potential of the metal elements 
used in total hip-arthroplasty components is a concern, 
particularly because the high surface area of porous-
coated devices inserted without cement is intended for 
implants used in younger, more active patients who may 
have a postoperative life expectancy of more than thirty 
years. The carcinogenic potential of these implant mate-
rials has been documented in animal studies446284. For 
example, Memoli et al. reported a small increase in the 
prevalence of sarcoma in rats that had an implant with 
a high cobalt, chromium, or nickel content69. Lympho-
mata with osseous involvement were also more com-
mon in rats with a metal implant69. Bouchard et al., also 
in a study of rats, noted tumors adjacent to the sites 
of both cobalt and titanium-based-alloy implants12. The 
tumors were associated with loosening of the implant, 
suggesting that a foreign-body reaction was the primary 
mechanism of carcinogenesis12. 
There have been a number of reports of tumors at 
the sites of implants in dogs and cats; most of these 
lesions have been osteosarcomas or fibrosarcomas as-
sociated with stainless-steel internal fixation devices7. 
There have been relatively few reports of malignant 
tumors associated with total joint replacements in hu-
mans48, but the number of case reports is increasing. 
Concerted efforts are currently under way to accumu-
late cases of malignant neoplasms associated with total 
joint replacements, in order to better define the risks 
prospectively241. 
There have been even fewer large-scale epidemio-
logical studies of the carcinogenic potential of metal 
implants. One such investigation documented an in-
creased prevalence of leukemia and lymphomata in pa-
tients who had a cobalt-alloy total hip replacement38. 
Other studies have supported this finding in patients who 
had a metal-on-metal device9899. Recent studies failed 
to confirm an increased prevalence of leukemia and lym-
phomata; however, they did not include as large a pro-
portion of subjects who had a metal-on-metal device396474. 
Interestingly, they also demonstrated a decreased prev-
alence of other site-specific malignant tumors, includ-
ing those of the lung64", breast38, and stomach7499. 
At this point in time, the association between release 
of metal from orthopaedic implants and any metabolic, 
bacteriological, immunological, or carcinogenic toxicity 
is conjectural. Cause and effect have not been estab-
lished in human subjects, in large part because most 
diseases that could result from systemic and remote 
metal toxicity can be expected to occur at a finite fre-
quency in any population of orthopaedic patients. Thus, 
the identification of disease processes related to but at 
a site remote from an implant depends either on the 
availability of comparative epidemiological data or on 
the ability to perform tests on the patient before and 
after removal of the device. Currently, there is a dearth 
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of such data with regard to any remote or systemic 
effects in patients who have had a joint-replacement 
procedure. 
Studies of Total Joint Replacement in Humans 
The presence of metal degradation products gen-
erated by corrosion and wear has been documented 
locally125-71 and systemically49255871'7677'90 in animal mod-
els28,29,108.n0 a n d m humans1.5.9-11.1425.26.47.49-55.58.71.72.76.77.87.90_ E a r l i e r 
studies were hampered by methodological problems, 
particularly contamination, involved with the measure-
ment of concentrations of metal in the parts-per-billion 
range72. More precise data have emerged as methodol-
ogy and instrumentation have evolved. 
Sunderman et al. reported increased levels of cobalt 
in the serum and urine six to 120 weeks after total knee 
replacement, and they noted substantially increased 
levels in two patients who had a loose prosthesis90. One 
of these two patients also had an increased level of 
chromium in the serum and urine, and transient in-
creases in the levels of nickel in the urine and serum 
were noted immediately postoperatively. Those authors 
concluded that there was no sign of metal toxicity in 
any of their patients, and all levels that were measured 
were within limits considered acceptable for occupa-
tional exposure90. 
Michel et al., in a prospective study of ten patients 
who had had a total knee arthroplasty with use of 
cobalt-based-alloy components, found a twofold in-
crease in the level of cobalt in the serum and whole 
blood ninety days after the operation72. In a companion 
retrospective study, four of twenty-three patients who 
had had a total hip or total knee replacement with use 
of cobalt-based-alloy components had levels of cobalt 
in the serum of more than two parts per billion (highest 
level, fifty parts per billion) less than one to 152 months 
postoperatively; the controls in that study had levels of 
0.33 part per billion72. None of the devices was reported 
to be loose, and no increase in the level of chromium 
in the serum was documented72. 
We performed several studies to investigate metal-
ion release after total joint replacement with use of 
titanium-based-alloy components. In a retrospective 
study, the concentration of titanium in the serum of 
twenty-one patients who had a loose titanium-containing 
total hip-replacement component was increased approx-
imately twofold compared with the level in twenty-one 
controls49. No significant differences were detected in 
the concentration of titanium or aluminum in the urine 
or in the concentration of aluminum in the serum be-
tween these two groups or between either of them and 
a group of twenty-one patients who had a stable implant. 
The concentration of vanadium was uniformly low in all 
three groups49. 
We also conducted a retrospective study of the se-
rum concentration and urinary excretion of metal 
in thirty-six patients who had total knee-replacement 
components containing titanium-based alloy and in 
twenty-one controls who did not have an implant52. The 
patients who had wear couples consisting of carbon-
fiber-reinforced polyethylene and titanium-based alloy 
had a tenfold increase in the concentration of titanium 
in the serum compared with the controls at a mean 
of four years after implantation. Equally dramatic, al-
though somewhat more predictable, were the increases 
noted in patients who had a failed metal-backed patel-
lar component in which unintended metal-on-metal ar-
ticulation was occurring. These individuals had the 
highest levels of titanium in the serum (mean, 114 parts 
per billion; range, fifteen to 285 parts per billion) — as 
much as two orders of magnitude higher than the val-
ues for the controls. Increases in the level of titanium 
in the urine, with values as high as 6.6 parts per billion, 
also were noted in this group. Interestingly, there was 
no increase in the level of-aluminum in the serum or 
urine in any group that was studied. The levels of va-
nadium in the serum and urine were too low to allow 
meaningful comparisons. 
Stulberg et al. reported substantial increases in the 
levels of titanium and aluminum as well as slight in-
creases in the levels of vanadium, cobalt, and chro-
mium in the serum of patients who had a failed patellar 
component87. 
Because of the inherent variability in metal-ion con-
tent between normal individuals (that is, those who do 
not have an implant)72 and in the same individual at 
different times, we performed a prospective, controlled, 
longitudinal study in which the level of metal in the 
serum of seventy-five patients was measured both be-
fore the operation and at regular intervals thereafter47. 
With use of this study design, each patient serves as his 
or her own control. Patients who had a well functioning 
primary total hip replacement with titanium-containing 
components had as much as a threefold increase in the 
concentration of titanium thirty-six months postopera-
tively, whereas those who had a well functioning pros-
thesis with cobalt-alloy components had increases in the 
levels of chromium in the serum and urine of as much 
as fivefold and eightfold, respectively. The predominant 
source of disseminated chromium-degradation products 
was probably the modular head-neck junction; passive 
dissolution of extensively porous-coated cobalt-alloy 
stems was not a dominant mode of metal release47. 
We also prospectively studied fifteen patients who 
had a total knee replacement, without cement, that in-
cluded a conventional polyethylene articular surface 
and a nitrogen ion-implanted titanium-alloy counter-
face50. Samples of serum, obtained for a maximum 
of sixty months postoperatively, revealed a twofold-to-
fivefold increase in the level of titanium at all of the 
intervals that were studied. All of the patients had an 
excellent clinical result and no evident radiographic 
complications. 
Because of the findings of mechanically assisted 
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crevice corrosion in patients who have had a total hip 
arthroplasty with use of a modular femoral stem21223465, 
we undertook a retrospective study to examine the 
levels of cobalt, chromium, and nickel in the serum 
and urine of patients in whom a modular implant had 
failed54. We found increases in the levels of cobalt in the 
serum and chromium in the urine of ten patients who 
had moderate-to-severe corrosion at the modular junc-
tion compared with ten controls and five patients who 
had no or mild corrosion54. 
The highest levels of cobalt and chromium in the 
serum and of chromium in the urine were observed in 
individuals who had a total hip system incorporating 
metal-on-metal bearing couples53. We found a ninefold 
increase in the level of chromium in the serum, a thirty-
fivefold increase in the level of chromium in the urine, 
and at least a threefold increase in the level of cobalt 
in the serum of eight patients in whom a McKee-Farrar 
total hip implant had been clinically successful for more 
than twenty years. Even higher increases were seen in 
six patients who had had a metal-on-metal surface-
replacement prosthesis for less than two years. 
Autopsy Studies 
Michel et al. reported on two postmortem specimens 
with cobalt-based-alloy total joint-replacement com-
ponents72. One specimen showed substantial increases 
in the concentration of cobalt in the heart, liver, and 
spleen, and the other showed an increased level of co-
balt in the lymphatic tissue and the heart. In addition, 
one specimen had an increased level of chromium in the 
aorta, heart, liver, pancreas, and spleen72. Dobbs and 
Minski also reported increased concentrations of cobalt 
and chromium in remote tissue (lung, kidney, liver, and 
spleen) in a cadaver that had bilateral cobalt-based-
alloy total hip components25. 
Case et al. reported the results of a study of thirteen 
cadavera that had an orthopaedic implant18. Five had 
stainless-steel dynamic hip screws; four, a stainless-steel 
total hip replacement; three, a cobalt-alloy hemiprosthe-
sis; and one, a stainless-steel and titanium-alloy total 
knee replacement. (The study included an additional 
seven cadavera that did not have an implant.) Metal 
originating from the implant was found in the local and 
distant lymph nodes and in the spleen, liver, and bone 
marrow with use of light and electron microscopy and 
inductively coupled plasma-mass spectrometry. The lev-
els of metal were highest in the cadavera that had a 
loose, worn implant18. 
We studied the levels of metal in remote as well 
as periprosthetic tissue in eight cadavera that had a to-
tal hip replacement with titanium-alloy components55. 
We compared the levels in the remote tissue with those 
measured in five control cadavera that did not have 
a metal implant. Initially, we focused on the levels of 
metal within the reticuloendothelial organs (the liver, 
spleen, and lung). In the control specimens, the levels 
of titanium, aluminum, and vanadium in the joint cap-
sule and spleen were generally lower than the limit for 
detection of these elements, whereas the concentrations 
of metal in the liver and lung tissue usually were detect-
able and were quite variable. The cadavera that had 
an implant had increased levels of titanium, aluminum, 
and vanadium in the joint pseudocapsule. Importantly, 
the levels of titanium in the spleen were significantly 
increased compared with those for the controls (p < 
0.01). Selected specimens also had increased concentra-
tions of titanium in the liver. The levels of metal in the 
lung were highly variable in the cadavera that did and 
did not have an implant. 
We recently performed a postmortem examination 
of a subject who had been enrolled in a prospective 
study of metal-ion release in association with primary 
total hip replacement47, so both longitudinal concentra-
tions of metal in the serum as well as concentrations in 
remote tissue could be measured. Markedly increased 
levels of titanium, aluminum, and vanadium were found 
in the periprosthetic (local) tissue; increased levels of 
titanium also were found in the spleen. However, the 
concentrations of titanium and aluminum in the serum 
had not increased over the three-year study period. 
Thus, even in the absence of an increase in the level 
of metal in the serum, deposition of metal can occur 
locally and in remote organ stores in association with 
a well functioning device55. 
Our autopsy studies have revealed that metal par-
ticles from joint-replacement components may migrate 
to the liver and spleen and that particulate corrosion 
products from these implants may migrate to regional 
and para-aortic lymph nodes5595. The presence of these 
disseminated particles was associated with multiple 
implants, revision of loose implants, and primary arthro-
plasty components that had been in situ for a long dura-
tion95. Although neither our series nor that of Case et al.18 
demonstrated toxic consequences from these systemi-
cally disseminated particles, a recent report documented 
symptomatic, granulomatous hepatitis in association 
with extensive deposition of titanium-alloy particles in a 
patient who had a failed total hip replacement4579. 
Future Directions 
Corrosion of orthopaedic implants remains a seri-
ous clinical concern. Even though the freely corroding 
implant materials used in the past have been replaced 
with modern corrosion-resistant superalloys, deleterious 
corrosion processes have been observed in certain clin-
ical settings. There is reason to believe that attention to 
variables related to metallurgical processing, tolerances 
of modular connections, surface-processing modalities, 
and appropriate selection of materials can decrease 
the rate of corrosion and minimize the potential for 
adverse clinical outcomes. For example, a recent study 
by Maurer et al. showed that nitriding can reduce the 
magnitude of fretting corrosion of Ti-6A1-4V devices66. 
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Similarly, Buchanan et al. found that implantation of have a metal implant need to be elucidated. Consider-
ions can improve the resistance to wear-accelerated cor- able work is required to discern the chemical form of 
rosion phenomena15'6. The mechanical-electrochemical the metal, the nature of its ligands, and ultimately the 
interactions of passive metal-oxide surfaces must be in- potential toxicity. 
vestigated further. The stresses and motion that are Metal implants for use in both permanent joint-
needed to fracture passivating oxide films, as well as the replacement components and internal fixation devices 
effects of repeated oxide abrasion on the electrochemi- are crucial tools in the armamentarium of the ortho-
cal behavior of the interface and ultimately the implant, paedic surgeon who treats traumatic, neoplastic, and 
are areas of active investigation. degenerative disorders of the musculoskeletal system. 
The role of particulate corrosion products in adverse For the most part, the application of these metal im-
local tissue reactions also needs to be investigated fur- plants has been quite successful, with few serious short 
ther. The initial studies described in this paper suggest and long-term clinical sequelae. However, as we gain 
that particulate corrosion products may play an impor- more experience with these devices, it is evident that, 
tant role in periprosthetic bone loss. These associations in certain situations, electrochemical degradative pro-
must be defined further with use of both clinical re- cesses may compromise the clinical outcome and lead 
trieval studies and in vitro cell-culture experiments. to adverse local and systemic effects. A continued 
Finally, the clinical ramifications of increases in metal awareness of these issues is needed within the ortho-
content in body fluids and remote organs of patients who paedic community. 
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